Handle with care: Ensuring LNP lipid quality for better genetic medicines by Matthew Stone | 0 CommentsLipid nanoparticles (LNPs) are widely used vehicles for oligonucleotide-based therapeutics and vaccines. However, LNPs can be susceptible to N-oxide-based impurities that can cause messenger RNA (mRNA) to lose function.
Handle with care: Ensuring LNP lipid quality for better genetic medicines by Matthew Stone | Biopharma, Blogs, ZenoTOF 7600 systemLipid nanoparticles (LNPs) are widely used vehicles for oligonucleotide-based therapeutics and vaccines. However, LNPs can be susceptible to N-oxide-based impurities that can cause messenger RNA (mRNA) to lose function.